Personalis Advances ctDNA Cancer Monitoring with AI Platform
Fremont, California | April 13, 2026 Personalis, Inc. has unveiled new data showcasing its ultrasensitive ctDNA-based cancer monitoring platform,...
biomarker discovery
Advertisement
NeoGenomics Advances AI-Driven Oncology Insights at AACR
Fort Myers, Florida | April 13, 2026 NeoGenomics, Inc. has announced the presentation of multiple scientific abstracts at the...
Imagene AI, Daiichi Sankyo Advance Oncology Biomarkers
Tel Aviv, Israel & Tokyo, Japan | April 9, 2026 Imagene AI has announced a strategic collaboration with Daiichi...
Tempus, Daiichi Sankyo Advance AI in ADC Oncology Trials
CHICAGO, Illinois, March 25, 2026 Tempus AI has announced a strategic collaboration with Daiichi Sankyo to accelerate AI-driven biomarker...
Single-Molecule Proteomics Targets Alpha-Synuclein in Parkinson’s
January 28, 2026 — Nautilus Biotechnology, Weill Cornell Medicine–Qatar (WCM-Q), and The Michael J. Fox Foundation (MJFF) have launched...
Advertisements
Arrayjet Opens US Printing Suite with Grace Bio Labs
BEND, Oregon | January 8, 2026 — Arrayjet, a provider of high-throughput microarray printing technologies, has opened its first...
Oncology NGS Market Accelerates as Precision Medicine Grows
Boston, MA – December 2025 – The global Clinical Oncology Next-Generation Sequencing (NGS) market is expanding rapidly as cancer...
Bio-Techne and Nucleai Advance AI Spatial Biology to Unlock Melanoma Biomarkers
MINNEAPOLIS, USA, and TEL AVIV, Israel, November 4, 2025 — Bio-Techne Corporation (NASDAQ: TECH) and Nucleai, an AI-driven precision-medicine...
Verily and UCHealth Launch AI Collaboration to Revolutionize Clinical Research
October 14, 2025 | Dallas, TX & Aurora, CO — Verily, UCHealth, the University of Colorado Anschutz, and RefinedScience...
Sanguine Enhances Cancer Research with Expanded Biospecimen Offerings
September 16, 2025 — San Diego, California Sanguine Biosciences has announced the expansion of its oncology biospecimen offerings through...
Advertisement
